Literature DB >> 20580320

MELAS with recurrent complex partial seizures, nonconvulsive status epilepticus, psychosis, and behavioral disturbances: case analysis with literature review.

Kenneth R Kaufman1, Nicole Zuber, Maria A Rueda-Lara, Anthony Tobia.   

Abstract

Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes (MELAS) is a progressive neurodegenerative disorder associated with polygenetic, maternally inherited, mitochondrial DNA mutations. MELAS has multisystem presentation including neurological, muscular, endocrine, auditory, visual, cardiac, psychiatric, renal, gastrointestinal and dermatological symptoms. Clinical course and prognosis are variable, often leading to cognitive decline, disability, and premature death. Both convulsive status epilepticus (CSE) and nonconvulsive status epilepticus (NCSE) are reported with MELAS. This report illustrates a case of MELAS with recurrent complex partial seizures, NCSE, confusion, aggressive behaviors, hallucinations, and paranoid delusions. Rapid video/EEG confirmation of diagnosis and aggressive antiepileptic drug intervention are required. Further education of medical professionals regarding this disorder, its appropriate management, and the significance of NCSE is indicated to avoid delay of treatment. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20580320     DOI: 10.1016/j.yebeh.2010.05.020

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  7 in total

1.  Sea food consumption for improving cardiac and cerebral manifestations of mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes.

Authors:  Fulvio A Scorza; Josef Finsterer
Journal:  Ann Transl Med       Date:  2017-09

2.  Phenotypic manifestations of the m.8969G>A variant.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Neurogenetics       Date:  2018-02-26       Impact factor: 2.660

Review 3.  Late-onset epilepsy and occult cerebrovascular disease.

Authors:  Lorna M Gibson; Martha F Hanby; Sarah M Al-Bachari; Laura M Parkes; Stuart M Allan; Hedley C A Emsley
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-12       Impact factor: 6.200

4.  Treatment of mitochondrial disorders.

Authors:  Sreenivas Avula; Sumit Parikh; Scott Demarest; Jonathan Kurz; Andrea Gropman
Journal:  Curr Treat Options Neurol       Date:  2014-06       Impact factor: 3.598

5.  Epilepsy, mental health disorder, or both?

Authors:  Vadim Beletsky; Seyed M Mirsattari
Journal:  Epilepsy Res Treat       Date:  2011-12-15

6.  Chronic kidney disease, severe arterial and arteriolar sclerosis and kidney neoplasia: on the spectrum of kidney involvement in MELAS syndrome.

Authors:  Giorgina Barbara Piccoli; Laura Davico Bonino; Paola Campisi; Federica Neve Vigotti; Martina Ferraresi; Federica Fassio; Isabelle Brocheriou; Francesco Porpiglia; Gabriella Restagno
Journal:  BMC Nephrol       Date:  2012-02-21       Impact factor: 2.388

7.  Consensus-based statements for the management of mitochondrial stroke-like episodes.

Authors:  Yi Shiau Ng; Laurence A Bindoff; Gráinne S Gorman; Rita Horvath; Thomas Klopstock; Michelangelo Mancuso; Mika H Martikainen; Robert Mcfarland; Victoria Nesbitt; Robert D S Pitceathly; Andrew M Schaefer; Doug M Turnbull
Journal:  Wellcome Open Res       Date:  2019-12-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.